Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Biomarkers of COPD Exacerbation

NCT03609541 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT03609541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Biomarkers of COPD Exacerbation
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
June 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

saa level and saa/lipoxin a4 ratio